the prognostic value of patient-reported outcomes in mds
Published 1 year ago • 45 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:06
the prognostic value of self-reported fatigue on overall survival in patients with mds
-
1:44
the importance of patient-reported outcomes in clinical trials & clinical practice
-
0:45
difference between quality of life & patient-reported outcomes
-
1:46
the importance of studying patient-reported outcomes in mpns
-
2:41
assessing the prognostic value of ngs-based mrd in adults with all undergoing sct
-
1:26
current and emerging prognostic factors for mds/mpn
-
55:44
low risk vs high risk mds - what's the difference?
-
1:04:28
understanding mds and mpn overlap syndrome
-
9:55
curative strategy for high-risk smoldering myeloma: post-hoc analysis of sustained undetectable mrd
-
2:40
what is the value of patient-reported outcomes?
-
1:44
patient reported outcomes in myeloid malignancies
-
1:17
the importance of patient reported outcomes in clinical trials
-
3:40
patient reported outcomes measures
-
3:35
real-world validation of the value of the ipss-m for prognostication in patients with mds
-
4:31
re-evaluating the use of iwg 2006 response criteria in mds
-
2:01
updates in mds diagnosis and prognosis with the ipss-m: personalized medicine in 2023
-
2:16
the potential use of proteomics for predicting relapse in patients with mds undergoing allosct
-
1:19
the prognostic value of mrd in cll
-
9:41
the i4mds consortium and immune monitoring in mds
-
0:49
integrating patient-reported outcomes into the ebmt registry
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
2:09
mds prognostic scores